Atlas Trials

Thrombocythemia Essential

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Thrombocythemia Essential

RecordFirmDate
An Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-7289-CTP-202/MK-3543-005) (NCT05223920)Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)2021-12-15
Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential Thrombocythemia (ET), Ph 2 (NCT04081220)The University of Texas Health Science Center at San Antonio2020-04-09
Prospective Study of Different Biological Tests (Multiplate, ROTEM) in a Cohort of Patients Followed for Essential Thrombocytemia (ET) (NCT03212053)Hospices Civils de Lyon2017-08-11
Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure (NCT02912884)Dr Yan Beauverd2016-09-01
Myeloproliferative Neoplasms and Bone Structure (NCT01816022)University of Southern Denmark2012-03-01
A Study in Myeloproliferative Disorders (NCT01134120)Eli Lilly and Company2010-04-01
A Safety Study of XL019 in Adults With Myelofibrosis (NCT00522574)Exelixis2007-08-01
Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments (NCT00567502)Shire2005-05-31

Track Thrombocythemia Essential automatically

Every clearance here is in the API, with alerts when new ones post.